ST 1481: Clinical Trials

5 trials of ST 1481, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 2 completed. 5 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Unknown 3, Completed 2
Phase 12Completed 2

Follow ST 1481: new trials by email Literature Review of ST 1481 trials Research Report on ST 1481

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Oral Gimatecan in Platinum-Resistant Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer
Gimatecan - Epithelial Ovarian Cancer, Fallopian Tube Cancer
Phase 2UnknownLee's Pharmaceutical Limited462021-07-012021-04-19
A Phase II Study of Gimatecan (ST1481) in Locally Advanced or Metastatic Pancreatic Cancer
Gimatecan, tegafur, gimeracil and oteracil potassium, gemcitabine - Pancreatic Cancer
Phase 2UnknownLee's Pharmaceutical Limited602020-12-012020-10-01
A Study of Gimatecan (ST1481) in Small Cell Lung Cancer
Gimatecan - Small Cell Lung Cancer
Phase 2UnknownLee's Pharmaceutical Limited702020-10-012020-08-06
Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma
gimatecan - Brain and Central Nervous System Tumors
Phase 1 / Phase 2CompletedJonsson Comprehensive Cancer Center2004-05-012013-07-18
This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Malignant Glioma.
Gimatecan® (ST 1481) - Malignant Glioma
Phase 1 / Phase 2CompletedSigma-Tau Research, Inc.592002-03-012009-06-03

Conditions studied

Astrocytoma (1)  ·  Brain Neoplasms (1)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Central Nervous System Neoplasms (1)  ·  Fallopian Tube Neoplasms (1)  ·  Glioblastoma (1)  ·  Glioma (1)  ·  Gliosarcoma (1)  ·  Oligodendroglioma (1)  ·  Pancreatic Neoplasms (1)  ·  Small Cell Lung Carcinoma (1)

Sponsors

Lee's Pharmaceutical Limited (3)  ·  Jonsson Comprehensive Cancer Center (1)  ·  Sigma-Tau Research, Inc. (1)

Countries

China (2)  ·  United States (2)

Top investigators

Timothy F. Cloughesy, MD (1)

Results publications

PMID 19819917, PMID 22722788